Theravance Biopharma Inc (TBPH)
Depreciation & Amortization
$4.42M
TTM · Period ending: · USD
TBPH Depreciation & Amortization
Latest reported$4.42Mperiod ending
Latest reported$4.42Mperiod ending
TBPH TTM Depreciation & Amortization ($2.65M → $4.42M)
TTM Depreciation & Amortization
High-resolution chart · PNG
TBPH depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 4,420,000 | |
| 3,904,000 | |
| 4,121,000 | |
| 3,310,000 | |
| 3,436,000 | |
| 3,488,000 | |
| 3,615,000 | |
| 4,337,000 | |
| 4,914,000 | |
| 4,859,000 | |
| 4,658,000 | |
| 5,266,000 | |
| 5,694,000 | |
| 6,679,000 | |
| 7,024,000 | |
| 7,389,000 | |
| 8,231,000 | |
| 8,738,000 | |
| 9,708,000 | |
| 8,449,000 | |
| 7,824,000 | |
| 7,663,000 | |
| 7,715,000 | |
| 7,692,000 | |
| 7,627,000 | |
| 6,886,000 | |
| 6,214,000 | |
| 5,964,000 | |
| 4,663,000 | |
| 3,939,000 | |
| 3,166,000 | |
| 3,326,000 | |
| 3,658,000 | |
| 3,844,000 | |
| 4,027,000 | |
| 4,184,000 | |
| 4,025,000 | |
| 3,503,000 | |
| 3,119,000 | |
| 2,641,000 | |
| 2,961,000 | |
| 3,102,000 | |
| 2,989,000 | |
| 2,461,000 | |
| 2,425,000 | |
| 2,516,000 | |
| 2,662,000 | |
| 3,187,000 | |
| 2,669,000 | |
| 2,682,000 | |
| 2,653,000 | |
| 2,701,000 | |
| 2,922,000 |